Wilkinson Samuel, Etheridge Tyler, Monson Bryan K, Larochelle Marissa B
John A. Moran Eye Center, University of Utah, 65 N Mario Capecchi, Salt Lake City, UT, 84132, USA.
Monson Vision, 810 S 100 W Ste A Logan, UT, 84321, USA.
Am J Ophthalmol Case Rep. 2022 Mar 25;26:101500. doi: 10.1016/j.ajoc.2022.101500. eCollection 2022 Jun.
We report a case of chronic post-operative endophthalmitis secondary to () in a patient with an implantable collamer lens (ICL).
A 45-year-old male presented three months after ICL implantation of the right eye with blurry vision, redness, and ocular pain in the setting of prolonged post-operative anterior chamber (AC) cell. Reduced visual acuity (VA) at 20/30-1, keratic precipitates, 1+ AC cell, and white ICL precipitates were concerning for chronic post-operative endophthalmitis. Anaerobic cultures from a vitreous tap grew . Multiple intravitreal and intracameral injections with topical steroids were required to maintain a stable VA at 20/30; however, inflammation persisted and removal of the ICL and his native lens was ultimately required.
Chronic post-operative inflammation and white plaque after ICL implantation should raise high suspicion for endophthalmitis secondary to . Anaerobic vitreous cultures can confirm the diagnosis. Removal of the ICL implant is often necessary for treatment. More research is needed to best manage this vision threatening condition.
我们报告一例植入可植入式胶原晶状体(ICL)的患者继发于()的慢性术后眼内炎病例。
一名45岁男性在右眼植入ICL三个月后出现视力模糊、眼红和眼痛,伴有术后前房(AC)细胞持续存在。视力(VA)降至20/30 - 1,角膜后沉着物,1+AC细胞,以及白色ICL沉着物提示慢性术后眼内炎。玻璃体穿刺的厌氧培养生长出()。需要多次玻璃体内和前房内注射局部类固醇以将VA维持在20/30稳定水平;然而,炎症持续存在,最终需要取出ICL及其天然晶状体。
ICL植入术后的慢性炎症和白色斑块应高度怀疑继发于()的眼内炎。厌氧玻璃体培养可确诊。治疗通常需要取出ICL植入物。需要更多研究以更好地管理这种威胁视力的疾病。